title: [Metformin for the treatment of polycystic ovary syndrome].
abstract: For several years there is an evidence for a relationship between the polycystic ovary syndrome (PCOS) and of insulin resistance; therefore metformin, an insulin sensitizer, is used for the treatment for more than 10 years. However, the evidence for metformin is assessed controversially. This review will give an overview about the data published on this topic.
authors.forename: Theresa
authors.initials: T
authors.lastname: Gundelach
authors.forename: Miriam
authors.initials: M
authors.lastname: Rodewald
authors.forename: Inga
authors.initials: I
authors.lastname: Bekes
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Janni
authors.forename: Katharina
authors.initials: K
authors.lastname: Hancke
mesh_terms: D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D008687:Metformin / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy*
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin